Itamifast (Diclofenac Potassium)

Diclofenac potassium works by reversibly inhibiting the cyclooxygenase‑1 and cyclooxygenase‑2 (COX‑1 and COX‑2) enzymes. This inhibition reduces the synthesis of prostaglandins, which are mediators of inflammation, pain, and fever, thereby providing analgesic and anti‑inflammatory effects throughout the body.

The appropriate dose of Itamifast is determined by the prescribing healthcare professional based on the individual’s medical condition, severity of symptoms, and overall health status. Patients should follow the prescriber’s instructions and not adjust the dose without medical guidance.

Safety of diclofenac potassium in pregnancy or lactation has not been definitively established. It is generally advised to avoid NSAIDs, including diclofenac, during the third trimester of pregnancy and to discuss potential risks with a healthcare provider before using it while pregnant or breastfeeding.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, and will request verification of trade or institutional credentials before providing pricing, availability, shipping details, and any necessary import documentation.

Itamifast (diclofenac potassium) is a fast‑acting NSAID that often provides quicker pain relief compared with some other oral NSAIDs such as ibuprofen. Its potassium salt form may be absorbed more rapidly, but the overall safety profile, including gastrointestinal and cardiovascular risks, remains similar to other NSAIDs.

Itamifast should be stored at ambient temperature below 25 °C. Keep the tablets in the original container, protect them from moisture and direct sunlight, and ensure they are out of reach of children.

Itamifast is taken orally, usually with a full glass of water. It may be taken with or without food, although taking it with food can help reduce gastrointestinal discomfort. The exact timing and frequency should follow the prescriber’s directions.

Serious risks include gastrointestinal bleeding or ulcer perforation, severe skin reactions such as Stevens‑Johnson syndrome, hepatic injury, renal impairment, and increased cardiovascular events. Patients should seek immediate medical attention if they experience symptoms like black stools, severe abdominal pain, rash, or unexplained swelling.

Itamifast should be avoided in individuals with known hypersensitivity to diclofenac, other NSAIDs, or any component of the formulation. It is also contraindicated in patients with active gastrointestinal ulceration, severe heart failure, or those who have had a recent coronary artery bypass graft surgery.